Moderna Doses First Participants in Phase I Trial of mRNA-1469: A Breakthrough Pursuit for a Bundibugyo Ebola Vaccine
Executive Overview In a monumental step forward for global health security, biotechnology pioneer Moderna has officially dosed its first participants...
